Literature DB >> 8116614

Severe neonatal Marfan syndrome resulting from a de novo 3-bp insertion into the fibrillin gene on chromosome 15.

D M Milewicz1, M Duvic.   

Abstract

Severe neonatal Marfan syndrome has features of the Marfan syndrome and congenital contractural arachnodactyly present at birth, along with unique features such as loose, redundant skin and pulmonary emphysema. Since the Marfan syndrome and congenital contractural arachnodactyly are due to mutations in different genes, it has been uncertain whether neonatal Marfan syndrome is due to mutations in the fibrillin gene on chromosome 15 or in another gene. We studied an infant with severe neonatal Marfan syndrome. Dermal fibroblasts were metabolically labeled and found to secret fibrillin inefficiently when compared with control cells. Reverse transcription and amplification of the proband's fibroblast RNA was used to identify a 3-bp insertion between nucleotides 480-481 or 481-482 of the fibrillin cDNA. The insertion maintains the reading frame of the protein and inserts a cysteine between amino acids 160 and 161 in an epidermal growth-factor-like motif of fibrillin. This 3-bp insertion was not found in the fibrillin gene in 70 unrelated, unaffected individuals and 11 unrelated individuals with the Marfan syndrome. We conclude that neonatal Marfan syndrome is the result of mutations in the fibrillin gene on chromosome 15 and is part of the Marfan syndrome spectrum.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8116614      PMCID: PMC1918129     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5' end.

Authors:  G M Corson; S C Chalberg; H C Dietz; N L Charbonneau; L Y Sakai
Journal:  Genomics       Date:  1993-08       Impact factor: 5.736

Review 2.  The Marfan syndrome: diagnosis and management.

Authors:  R E Pyeritz; V A McKusick
Journal:  N Engl J Med       Date:  1979-04-05       Impact factor: 91.245

3.  "New" syndrome of congenital contractural arachnodactyly originally described by Marfan in 1896.

Authors:  F Hecht; R K Beals
Journal:  Pediatrics       Date:  1972-04       Impact factor: 7.124

4.  Congenital contractural arachnodactyly. A heritable disorder of connective tissue.

Authors:  R K Beals; F Hecht
Journal:  J Bone Joint Surg Am       Date:  1971-07       Impact factor: 5.284

5.  Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome.

Authors:  L Pereira; M D'Alessio; F Ramirez; J R Lynch; B Sykes; T Pangilinan; J Bonadio
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

6.  Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene.

Authors:  H C Dietz; R E Pyeritz; E G Puffenberger; R J Kendzior; G M Corson; C L Maslen; L Y Sakai; C A Francomano; G R Cutting
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

7.  Deficiencies of fibrillin and decorin in fibroblast cultures of a patient with neonatal Marfan syndrome.

Authors:  A Superti-Furga; M Raghunath; P J Willems
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

8.  The skipping of constitutive exons in vivo induced by nonsense mutations.

Authors:  H C Dietz; D Valle; C A Francomano; R J Kendzior; R E Pyeritz; G R Cutting
Journal:  Science       Date:  1993-01-29       Impact factor: 47.728

9.  Decreased extracellular deposition of fibrillin and decorin in neonatal Marfan syndrome fibroblasts.

Authors:  M Raghunath; A Superti-Furga; M Godfrey; B Steinmann
Journal:  Hum Genet       Date:  1993-01       Impact factor: 4.132

10.  Tyrosine 67 in the epidermal growth factor-like domain of tissue-type plasminogen activator is important for clearance by a specific hepatic receptor.

Authors:  R Bassel-Duby; N Y Jiang; T Bittick; E Madison; D McGookey; K Orth; R Shohet; J Sambrook; M J Gething
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

View more
  20 in total

1.  Familial occurrence of typical and severe lethal congenital contractural arachnodactyly caused by missplicing of exon 34 of fibrillin-2.

Authors:  M Wang; C L Clericuzio; M Godfrey
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

2.  Identification of a de novo BRCA1 mutation in a woman with early onset bilateral breast cancer.

Authors:  Emma Edwards; Catharina Yearwood; Julie Sillibourne; Diana Baralle; Diana Eccles
Journal:  Fam Cancer       Date:  2009-07-21       Impact factor: 2.375

Review 3.  Tissue elasticity and the ageing elastic fibre.

Authors:  Michael J Sherratt
Journal:  Age (Dordr)       Date:  2009-12

4.  Evolving phenotype of Marfan's syndrome.

Authors:  K J Lipscomb; J Clayton-Smith; R Harris
Journal:  Arch Dis Child       Date:  1997-01       Impact factor: 3.791

5.  Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 gene.

Authors:  G Collod-Béroud; C Béroud; L Adès; C Black; M Boxer; D J Brock; M Godfrey; C Hayward; L Karttunen; D Milewicz; L Peltonen; R I Richards; M Wang; C Junien; C Boileau
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

6.  Double mutant fibrillin-1 (FBN1) allele in a patient with neonatal Marfan syndrome.

Authors:  M Wang; P Kishnani; M Decker-Phillips; S G Kahler; Y T Chen; M Godfrey
Journal:  J Med Genet       Date:  1996-09       Impact factor: 6.318

7.  A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome.

Authors:  D M Milewicz; J Grossfield; S N Cao; C Kielty; W Covitz; T Jewett
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

8.  Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: genetic drift as a robust and parsimonious hypothesis.

Authors:  Amos Frisch; Roberto Colombo; Elena Michaelovsky; Mazal Karpati; Boleslaw Goldman; Leah Peleg
Journal:  Hum Genet       Date:  2004-01-15       Impact factor: 4.132

9.  Marfan syndrome: fibrillin expression and microfibrillar abnormalities in a family with predominant ocular defects.

Authors:  C M Kielty; S J Davies; J E Phillips; C J Jones; C A Shuttleworth; S J Charles
Journal:  J Med Genet       Date:  1995-01       Impact factor: 6.318

10.  A compound-heterozygous Marfan patient: two defective fibrillin alleles result in a lethal phenotype.

Authors:  L Karttunen; M Raghunath; L Lönnqvist; L Peltonen
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.